Lancome Paris Skin Feels Good Broad Spectrum Spf 23 Sunscreen Hydrating Skin Tint Healthy Glow Liquid
NDC Package 51150-736-01
Package Information
Lancome Paris Skin Feels Good Broad Spectrum Spf 23 Sunscreen Hydrating Skin Tint Healthy Glow (octinoxate) liquids is for sunscreen use:● shake well● apply liberally 15 minutes before sun exposure● reapply at least every 2 hours● use a water resistant sunscreen if swimming or sweating● Sun Protection Measures. This formulation utilizes a liquid delivery system. Marketed by Sicos Et Cie, this product is identified by NDC 51150-736 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51150 - Sicos Et Cie
- 51150-736 - Lancome Paris Skin Feels Good Broad Spectrum Spf 23 Sunscreen Hydrating Skin Tint Healthy Glow
- 51150-736-01 - 1 TUBE in 1 CARTON / 32 mL in 1 TUBE
- 51150-736 - Lancome Paris Skin Feels Good Broad Spectrum Spf 23 Sunscreen Hydrating Skin Tint Healthy Glow
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51150-736). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51150-736-01 identifies a specific commercial package of 1 tube in 1 carton / 32 ml in 1 tube of Lancome Paris Skin Feels Good Broad Spectrum Spf 23 Sunscreen Hydrating Skin Tint Healthy Glow, a human over the counter drug labeled by Sicos Et Cie. This liquid is formulated for topical use and contains octinoxate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sicos Et Cie on November 01, 2017. The current certification is valid through December 31, 2026.
How is this Sicos Et Cie product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51150073601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.